Nilkamal Limited has informed the Exchange that Board of Directors at its meeting held on May 14, 2025, recommended Final Dividend of 20 per equity share.
NILKAMAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nilkamal's Board, at its May 14, 2025 meeting, approved audited results for Q4 and FY ended March 31, 2025, and recommended a Final Dividend of Rs. 20 (200%) per equity share on a face value of Rs. 10, subject to shareholder approval at the July 18, 2025 AGM. Standalone FY25 revenue from operations rose to Rs. 3,23,931.79 lakhs (from Rs. 3,13,410.96 lakhs), but net profit after tax fell to Rs. 9,127.08 lakhs (from Rs. 10,731.22 lakhs), a ~15% YoY decline, with basic EPS at Rs. 61.16 vs Rs. 71.91. The Board also approved the acquisition of the healthcare business of Imedfurns Private Limited (including IP, contracts, employees) for Rs. 4 crores, payable over 4 years. Record date for the dividend is July 11, 2025.
Despite higher topline, profit contraction and a moderate Rs. 20 final dividend may temper near-term investor enthusiasm, though the small Imedfurns healthcare acquisition signals diversification into the medical furniture segment. Shareholders on record by July 11, 2025 will be eligible for the dividend payout on or after July 25, 2025.